What will be the market price of Platinib in 2025?

Pralsetinib is a targeted anti-cancer drug, mainly used to treat non-small cell lung cancer (NSCLC) and some other tumors carrying RET gene mutations. As a new type of kinase inhibitor, platinib prevents the growth and spread of tumor cells by specifically inhibiting the activity of RET protein. In recent years, with the development of precision medicine, the use of targeted drugs has become increasingly popular, and platinib has attracted much attention due to its good clinical effects.

In the Chinese market, the original drug Platinib has been approved and marketed, but because it has not yet been included in the medical insurance system, its price is still quite expensive. Common packaging specifications include 100mg 60 capsules and 100mg 120 capsules. The price of a box is usually more than 20,000 yuan, and in some areas, the price is even as high as 60,000 yuan. This price puts pressure on many patients, especially when financial conditions are limited. How to afford long-term medication has become a serious problem.

In addition, platinib is more expensive in overseas markets. For example, in some countries and regions, the price of Platinib in a 60-pill package may fluctuate between 40,000 to more than 100,000 yuan. The specific price is affected by exchange rates, market demand, and sales channels. Against this background, patients have to consider economic factors and accessibility issues when choosing medications.

In order to cope with the high drug costs, pharmaceutical companies in some countries and regions have begun to develop generic versions of Platinib. Compared with brand-name drugs, generic drugs are usually less expensive and can provide patients with more choices. For example, the price of 120 tablets of platinib generic drug produced in Laos is only around RMB 3,000, which undoubtedly reduces the financial burden on patients. However, when choosing generic drugs, patients must pay attention to the quality and source of the drugs to ensure their safety.

Reference: https://gavreto.com/